Summary
Five pyridoxine-non-responsive homocystinuric patients aged 5 to 32 years were treated with oral betaine, 3 g b.i.d, in a double-blind, placebo-controlled, two-year crossover study of its effect on bone mineralization. Betaine therapy significantly reduced mean plasma homocystine (36±9 (SEM) µmol L−1 to 9±4 µmol L−1), with variable increases in plasma methionine and no adverse effects. Bone density, measured by computerized tomographic scanning of vertebral bodies, was below normal in all patients at the start of the study, and was not significantly altered by betaine therapy administered according to this protocol
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brenton, D. P., Cusworth, D. C., Dent, C. D., and Jones, E. Homocystinuria: clinical and dietary studies.Q. J. Med. 35 (1966) 325–346
Cann, C. E., and Genant, H. K. Precise measurement of vertebral mineral content using computed tomography.J. Comput. Assist. Tomogr. 4 (1980) 493–500
Cann, C. E., Martin, M. C., Genant, H. K., and Jaffe, R. B. Decreased spinal mineral content in amenorrheic women.J. Am. Med. Assoc. 251 (1984) 626–629
Gahl, W. A., Finkelstein, J. D., Mullen, K. D., Bernardini, I., Martin, J. J., Backlund, P., Ishak, K. G., Hoofnagle, J. H., and Mudd, S. H. Hepatic methionine adenosyltransferase deficiency in a 31-year-old man.Am. J. Hum. Genet. 40 (1987) 39–49
Genant, H. K., Cann, C. E., Ettinger, B., and Gordan, G. S., Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy.Ann. Intern. Med. 97 (1982) 699–705
Genant, H. K., Ettinger, B., Cann, C. E., Reiser, U., Gordan, G. S., and Kolb, F. O. Osteoporosis: Assessment by quantitative computed tomography.Orth. Clin. N. Am. 16 (1985) 557–568
Komrower, G. M. and Sardharwalla, I. B. The dietary treatment of homocystinuria. In Carson, N. A. J., and Raine, D. N. (eds.)Inherited Disorders of Sulphur Metabolism, Churchill Livingstone, Edinburgh, 1971, pp. 254–263
Louis, T. A., Lavori, P. W., Bailar, J. C. III, and Polansky, M. Crossover and self-controlled designs in clinical research.N. Engl. J. Med. 310 (1984) 24–31
Mudd, S. H., and Levy, H. L. Disorders of transsulfuration. In Stanbury, J. B., Wyngaarden, J. B., Fredrickson, D. S., Goldstein, J. L., and Brown, M. S. (eds.)The Metabolic Basis of Inherited Diseases, 5th edn., McGraw-Hill, New York, 1983, pp. 522–559
Mudd, S. H., Skovby, F., Levy, H. L., Pettigrew, K. D., Wilcken, B., Pyeritz, R. E., Andria, G., Boers, G. H. J., Bromberg, I. L., Cerone, R., Fowler, B., Grobe, H., Schmidt, H., and Schweitzer, L. The natural history of homocystinuria due to cystathionine β-synthase deficiency.Am. J. Hum. Genet. 37 (1985) 1–31
Smolin, L. A., Benevenga, N. J., and Berlow, S. The use of betaine for the treatment of homocystinuria.J. Pediatr. 99 (1981) 467–472
Wendel, U., and Bremer, H. J. Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency.Eur. J. Pediatr. 142 (1984) 147–150
Wilcken, D. E. L., Dudman, N. P. B., and Tyrrell, P. A. Homocystinuria due to cystathione β-synthase deficiency — The effects of betaine in pyridoxine-responsive patients.Metabolism 34 (1985) 1115–1121
Wilcken, D. E. L., Wilcken, B., Dudman, N. P. B., and Tyrrell, P. A. Homocystinuria — The effects of betaine in the treatment of patients not responsive to pyridoxine.N. Engl. J. Med. 309 (1983) 448–453
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gahl, W.A., Bernardini, I., Chen, S. et al. The effect of oral betaine on vertebral body bone density in pyridoxine-non-responsive homocystinuria. J Inherit Metab Dis 11, 291–298 (1988). https://doi.org/10.1007/BF01800372
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01800372